Xiaohong Ma

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 10

Top Topics

Endometrial Cancer

Binding Protein

Estrogen Receptor

Top Venues

Cell death & disease

Cell death discovery

Cancer medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Lina Wei, Xiaohong Ma, Yixin Hou, Tianyi Zhao, Rui Sun, Chunping Qiu, Yao Liu, Ziyi Qiu, Zhiming Liu, Jie Jiang
Verteporfin reverses progestin resistance through YAP/TAZ-PI3K-Akt pathway in endometrial carcinoma. Cell death discovery 9 (1) (2023)
Lina Wei, Xiaohong Ma, Yixin Hou, Tianyi Zhao, Rui Sun, Chunping Qiu, Yao Liu, Ziyi Qiu, Zhiming Liu, Jie Jiang
Verteporfin reverses progestin resistance through YAP/TAZ-PI3K-Akt pathway in endometrial carcinoma. Cell death discovery 9 (1) (2023)
Lina Wei, Xiaohong Ma, Yixin Hou, Tianyi Zhao, Rui Sun, Chunping Qiu, Yao Liu, Ziyi Qiu, Zhiming Liu, Jie Jiang
Verteporfin reverses progestin resistance through YAP/TAZ-PI3K-Akt pathway in endometrial carcinoma. Cell death discovery 9 (1) (2023)
Xiaohong Ma, Min Xia, Lina Wei, Kui Guo, Rui Sun, Yao Liu, Chunping Qiu, Jie Jiang
ABX-1431 inhibits the development of endometrial adenocarcinoma and reverses progesterone resistance by targeting MGLL. Cell death & disease 13 (12) (2022)
Xiaohong Ma, Min Xia, Lina Wei, Kui Guo, Rui Sun, Yao Liu, Chunping Qiu, Jie Jiang
ABX-1431 inhibits the development of endometrial adenocarcinoma and reverses progesterone resistance by targeting MGLL. Cell death & disease 13 (12) (2022)
Xiaohong Ma, Min Xia, Lina Wei, Kui Guo, Rui Sun, Yao Liu, Chunping Qiu, Jie Jiang
ABX-1431 inhibits the development of endometrial adenocarcinoma and reverses progesterone resistance by targeting MGLL. Cell death & disease 13 (12) (2022)
Xiaohong Ma, Min Xia, Lina Wei, Kui Guo, Rui Sun, Yao Liu, Chunping Qiu, Jie Jiang
ABX-1431 inhibits the development of endometrial adenocarcinoma and reverses progesterone resistance by targeting MGLL. Cell death & disease 13 (12) (2022)
Xiaohong Ma, Min Xia, Lina Wei, Kui Guo, Rui Sun, Yao Liu, Chunping Qiu, Jie Jiang
ABX-1431 inhibits the development of endometrial adenocarcinoma and reverses progesterone resistance by targeting MGLL. Cell death & disease 13 (12) (2022)
Xiaohong Ma, Tianyi Zhao, Hong Yan, Kui Guo, Zhiming Liu, Lina Wei, Wei Lu, Chunping Qiu, Jie Jiang
Fatostatin reverses progesterone resistance by inhibiting the SREBP1-NF-κB pathway in endometrial carcinoma. Cell death & disease 12 (6) (2021)
Qing Zhou, Wenzhi Li, Deshui Kong, Zhiming Liu, Zhengzheng Shi, Xiaohong Ma, Yongmei Li, Jie Jiang
DACH1 suppresses epithelial to mesenchymal transition (EMT) through Notch1 pathway and reverses progestin resistance in endometrial carcinoma. Cancer medicine 8 (9) (2019)